UCL Technology Fund
Venture capitalLondon · Pre-Seed–Growth · 14 people tracked
Investment thesis
UCL Technology Fund backs founders and research teams commercialising physical and life sciences ideas originating from University College London. Investing since 2016, the fund supports the full commercialisation journey, from proof-of-concept and development projects through to company formation. It combines capital with scale-up expertise, helping researchers turn scientific discoveries into viable companies. The fund also engages in licensing projects and proof-of-concept investments as part of translating UCL research into commercial outcomes.
Source: firm website, verified Aug 3, 2026.
Team · 14 people
from the firm's website & curated
What they invest in
from 20 of 27 portfolio companiesDeep Tech ×11Biotech ×10Healthtech ×10AI & Machine Learning ×8Medical Devices ×7Hardware ×4Advanced Manufacturing ×2Cleantech ×2
HQs:United Kingdom×9United States×2
Who they back
founder profiles across 8 portfolio companiesFounding team size:solo founder×22 founders×23 founders×34+ founders×1
Investments · 27 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 12024 · 14 dated
Clinical-stage gene therapy company developing treatments for ocular diseases (NASDAQ: MGTX).
Co-investorsAlbionVC
Echopoint Medical develops cardiac technology focused on coronary physiology for interventional cardiology.
Deep TechHardwareHealthtechMedical DevicesLondon, GB
Antony Odell(CEO & Co-Founder)inMalcolm Finlay(CMO & Co-Founder)inAdrien Desjardins(CSO & Co-Founder)inPriscila Hancock(Executive Officer)Nijs van de Vaart(COO)inPri Hancock(CFO)in
Co-investorsQueen Mary University of LondonAlbionVCParkwalk Advisors
AstronauTx is a biotechnology company focused on drug discovery and development for neurodegenerative and neuroinflammatory diseases, working across small molecules and biologics.
BiotechDeep TechHealthtechLongevityMedical Devices
Jane Rhodes(Chief Executive Officer)Magnus Ivarsson(Chief Scientific Officer)Hannah Pearce(Chief Operating Officer)Michelle L. Mellion(Chief Medical Officer)
Co-investorsMPM BioImpactNovartis Venture FundSV Health Investors
Co-investorsAlbionVC
Gigaton builds AI control systems for cement plants that continuously learn and adapt to optimize production while reducing costs and carbon emissions.
Advanced ManufacturingAI & Machine LearningCleantechClimate Tech
Co-investorsClean Growth FundSemapa Next
Co-investorsUK Innovation & Science Seed Fund
Intrinsic Semiconductor Technologies develops resistive random-access memory (RRAM) technology for non-volatile memory applications, enabling faster data access and write speeds with lower power consumption.
AI & Machine LearningDeep TechHardwareSemiconductorsLondon, GB
Dr Adnan Mehonic(Founder)Professor Tony Kenyon(Founder)Zack Deiri(President & CEO)
Co-investorsAlbionVCOctopus Ventures
Industrial augmented reality solution guiding and monitoring shopfloor workers.
Co-investorsArmilar Venture PartnersBlueCrow CapitalCriteria Venture TechRKKVC
Meira GTx develops genetic medicine treatments for patients with devastating diseases, leveraging expertise in drug development and manufacturing.
BiotechDeep TechHealthtechMedical Devices
Co-investorsAlbionVCOberland Capital
Co-investorsAlbionVC
Quell Therapeutics is a clinical-stage biopharmaceutical company developing targeted Treg cell therapies with advanced manufacturing capabilities.
BiotechDeep TechHealthtechMedical Devices
Co-investorsAlbionVCJeito Capital
Co-investorsAlbionVCBlackfinch Ventures
A portfolio biopharmaceutical company that translates breakthroughs in biology and basic medical research from top universities into novel therapeutics.
BiotechHealthtechCambridge, GB
Co-investorsPatient Square CapitalRock Springs CapitalAlbionVC
EpilepsyGTx is a preclinical-stage biotech developing gene therapies for focal refractory epilepsy (FRE), with the aim of making patients seizure free.
BiotechDigital Health
Co-investorsAlbionVCMoonstone Venture CapitalXGEN VentureBritish Business Bank
Epsilogen develops antibody therapeutics based on the IgE, IgA, and IgG immunoglobulin isotypes for the treatment of cancer, matching each isotype to specific tumor types and combining isotypes into single antibody molecules.
BiotechHealthtech
Tim Wilson(Chief Executive Officer)Kevin FitzGerald(Chief Scientific Officer)inCristina Oliva(Chief Medical Officer)inNick Robbins-Cherry(Chief Financial Officer)inElizabeth Hardaker(Chief Translational Science Officer)
Co-investors3B Future Health FundAlbionVCEpidarex CapitalGlobal BioAccess FundNovartis Venture FundBioGeneration Ventures
Gaussion develops magnetic battery control technology that improves charging speed, heat generation, and lifetime performance across different cell formats and chemistries for electric vehicles, stationary storage, and industrial applications.
Deep TechEnergyHardwareLondon, GB
Tom Heenan(Founder)in
Co-investorsAutotech VenturesFuture VenturesAlbionVCDN Capital
Gigaton builds AI-powered control systems for energy-intensive industries to autonomously optimize operations and reduce costs and carbon emissions.
Advanced ManufacturingAI & Machine LearningCleantechClimate TechNew Materials
Co-investorsClean Growth FundSemapa NextAlbionVCPlanet A Ventures
Humanloop was a development platform for building and managing large language model applications, providing tools for evaluating and managing AI systems.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US
Raza Habib(Founder)inJordan Burgess(Founder)inPeter Hayes(Founder)in
Co-investorsAlbionVCIndex VenturesY CombinatorLocalGlobe
NovalGen is a clinical-stage biotechnology company developing multi-specific biologics for oncology, autoimmune, haematological, and metabolic disorders using its proprietary AutoRegulation platform technology.
BiotechHealthtechLongevityMedical DevicesLondon, GB
Co-investorsAlbionVC
Orchard Therapeutics develops ex vivo autologous hematopoietic stem cell (HSC) gene therapies for genetic and other severe diseases, including rare inherited conditions such as ADA-SCID and metachromatic leukodystrophy.
BiotechDeep TechHealthtechMedical DevicesLondon, GB
Donald Kohn(Scientific Founder)Adrian Thrasher(Scientific Founder)Frank E. Thomas(Executive Officer)inSteven M. Altschuler(Director)John Curnutte(Director)
BoardBobby Gaspar(Scientific Founder)in
Co-investorsAlbionVCF-Prime CapitalForesite CapitalAgent CapitalBaillie GiffordORI Capital+1 more
Oriole Networks develops PRISM, an all-optical circuit-switched networking fabric that uses photonic switching to connect GPUs at scale for AI/ML and high-performance computing data centers.
AI & Machine LearningDeep TechHardwareLondon, GB
George Zervas(Co-founder)inAlessandro Ottino(Co-founder)inJoshua Benjamin(Co-founder)inJames Regan(CEO)in
Co-investorsAlbionVCClean Growth FundPluralXTX Markets
Phasecraft develops quantum computing systems and software by combining quantum information theory, materials science, and engineering to advance practical quantum advantage.
AI & Machine LearningDeep TechQuantum Computing
Prof. Ashley Montanaro(Co-Founder & CEO)inProf. Toby Cubitt(Co-Founder, CTO & CSciO)inProf. John Morton(Co-Founder & Director)in
Co-investorsAlbionVCEpisode1Playground Global
Pometry provides a temporal graph database platform with AI infrastructure tools for querying and analyzing time-aware data across business, technical, and AI agent contexts.
AI & Machine LearningData & InfrastructureEnterprise Software
Alhamza Alnaimi(Founder)in
Co-investorsAlbionVCCambridge Angels groupCrane Venture Partners
Spur Therapeutics develops gene therapy treatments for genetic diseases, aiming to bring genetic medicine therapies to patients worldwide.
BiotechDigital HealthHealthtechMedical Devices
BoardChris(Chair (until August 2026), Chief Executive Officer)
Co-investorsAlbionVC
Stanhope AI develops a Free Energy Minimizing (FEM) world model, an AI architecture for autonomous machines that controls behavior, enables mission planning, and supports human-machine teaming.
AI & Machine LearningDeep TechRoboticsLondon, GB
Rosalyn Moran(Founder & CEO)in
BoardKarl Friston(Scientific Adviser)
Co-investorsAlbionVCAuxxoMMC VenturesMoonfire VenturesPaladin Capital GroupFrontline Ventures
Exits · 1
IPOs and acquisitions across the tracked portfolioMeiraGTxNASDAQ: MGTX
Portfolio news
latest coverage across their companiesOrchard Therapeutics · x.com · Aug 8, 2026
Gaussion · startuprise.co.uk · Jun 29, 2026
Gigaton · pulse2.com · Jun 8, 2026
Oriole Networks · siliconangle.com · Jun 8, 2026
Humanloop · news.crunchbase.com · Apr 2, 2026
Stanhope AI · eu-startups.com · Feb 13, 2026
Epilepsy GTx · clinicaltrialsarena.com · Dec 11, 2025
Frequently asked questions
- How many investments has UCL Technology Fund made?
- UCL Technology Fund has 26 tracked investments, 1 of which have exited via acquisition or IPO, including 4 dated in the last 24 months.
- What stage does UCL Technology Fund invest at?
- UCL Technology Fund invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.
- What is UCL Technology Fund's typical check size?
- UCL Technology Fund typically writes checks of $320K – $9M.
- What sectors does UCL Technology Fund focus on?
- UCL Technology Fund focuses on AI & Machine Learning, Biotech, Deep Tech, Healthtech, IoT, Longevity, New Materials.
- Where is UCL Technology Fund located?
- UCL Technology Fund is headquartered in London, GB.
- Who does UCL Technology Fund co-invest with?
- UCL Technology Fund most often shares deals with AlbionVC, Novartis Venture Fund, Episode1, among 38 tracked co-investors.
Media · Podcasts & interviews
from their channelFounder Stories University Edition with Professor Tony Kenyon, CSO & Co-founder Intrinsic.
UCL Technology Fund
Founder Stories University Edition with Ashley Montanaro, CEO & Co-founder Phasecraft
UCL Technology Fund
Founder Stories University Edition with Professor Amit Nathwani, CEO NovalGen
UCL Technology Fund
Founder Stories: Rosalyn Moran, CEO Stanhope AI
UCL Technology Fund
UCLTF Showcase 2022 - Highlights
UCL Technology Fund
Universities supporting Climate Tech - UCLTF Climate Tech Webinar
UCL Technology Fund
Similar investors
LIFTT is a venture capital holding company focused on deep tech technologies, using an operational, multi-vertical approach aimed at generating impact. It works to transform scientific research into high-impact companies, accelerating the path from lab to market.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
Ahren Innovation Capital is a deep-tech investment firm that backs companies emerging at the intersection of breakthrough science and advanced technology, supported by science partners and strategic LP relationships.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Fundamental Ventures is an early-stage venture firm that backs founders removing fundamental constraints holding back human progress, spanning hard tech, deep science, and network/workflow innovations.